FOLH1错义突变与NAAG水平降低及工作记忆环路和认知受损的关联
该研究探讨FOLH1基因变异对NAAG水平及认知的影响,发现rs202676 G等位基因与FOLH1 mRNA升高、NAAG水平降低相关,低NAAG携带者IQ较低且工作记忆时皮层活动效率下降,提示升高NAAG可能改善认知。
要点
- FOLH1 rs202676 G等位基因与背外侧前额叶FOLH1 mRNA升高及NAAG水平降低相关。
- NAAG水平与视觉记忆表现正相关,低NAAG携带者IQ评分较低。
- 低NAAG携带者工作记忆时皮层活动效率降低,NAAG和fMRI或可作生物标志物。
核心结论
- 较高NAAG水平与更好认知相关,通过抑制FOLH1/GCPII升高NAAG可能改善认知。
- MRS测得的NAAG水平和fMRI测得的皮层效率有潜力作为未来临床试验的神经影像生物标志物。
研究设计与样本
- 研究测量FOLH1遗传变异对人脑mRNA表达和7-T磁共振波谱(MRS)测得NAAG水平的影响。
- 在精神病患者和未患病受试者中分析NAAG水平及FOLH1遗传变异与认知指标的关联。
- 用功能MRI(fMRI)分析FOLH1遗传变异与工作记忆时神经活动的关联。
主要发现
- FOLH1错义突变(rs202676 G等位基因)与未患病受试者和精神分裂症患者背外侧前额叶FOLH1 mRNA增加相关。
- 该FOLH1变异与未患病受试者和精神病患者NAAG水平降低相关。
- NAAG水平与视觉记忆表现正相关。
- 与低NAAG相关的FOLH1变异携带者IQ评分较低。
- 该FOLH1变异携带者在工作记忆时皮层活动效率较低。
临床怎么用
- FOLH1/GCPII抑制以升高NAAG可能成为改善认知的潜在靶点。
- NAAG水平和工作记忆皮层效率可作为未来临床试验的候选神经影像生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Altering the metabotropic glutamate receptor 3 (mGluR3) by pharmacology or genetics is associated with differences in learning and memory in animals and humans. GRM3 (the gene coding for mGluR3) is also genome-wide associated with risk for schizophrenia. The neurotransmitter N-acetyl-aspartyl-glutamate (NAAG) is the selective endogenous agonist of mGluR3, and increasing NAAG may improve cognition. Glutamate carboxypeptidase II (GCPII), coded by the gene folate hydrolase 1 (FOLH1), regulates the amount of NAAG in the synapse. The goal of this study was to determine the relationship between FOLH1, NAAG levels, measures of human cognition, and neural activity associated with cognition. METHODS: The effects of genetic variation in FOLH1 on mRNA expression in human brain and NAAG levels using 7-T magnetic resonance spectroscopy (MRS) were measured. NAAG levels and FOLH1 genetic variation were correlated with measures of cognition in subjects with psychosis and unaffected subjects. Additionally, FOLH1 genetic variation was correlated with neural activity during working memory, as measured by functional MRI (fMRI). RESULTS: A missense mutation in FOLH1 (rs202676 G allele) was associated with increased FOLH1 mRNA in the dorsolateral prefrontal cortex of brains from unaffected subjects and schizophrenia patients. This FOLH1 variant was associated with decreased NAAG levels in unaffected subjects and patients with psychosis. NAAG levels were positively correlated with visual memory performance. Carriers of the FOLH1 variant associated with lower NAAG levels had lower IQ scores. Carriers of this FOLH1 variant had less efficient cortical activity during working memory. CONCLUSIONS: These data show that higher NAAG levels are associated with better cognition, suggesting that increasing NAAG levels through FOLH1/GCPII inhibition may improve cognition. Additionally, NAAG levels measured by MRS and cortical efficiency during working memory measured by fMRI have the potential to be neuroimaging biomarkers for future clinical trials.
引用
- Zink CF, Barker PB, Sawa A, et al. Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition. Am J Psychiatry. 2020. PMID: 33256444. doi:10.1176/appi.ajp.2020.19111152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。